Antioxidant Nano-Therapies for Aging-Related Diseases
A special issue of Antioxidants (ISSN 2076-3921). This special issue belongs to the section "Health Outcomes of Antioxidants and Oxidative Stress".
Deadline for manuscript submissions: 30 October 2024 | Viewed by 52
Special Issue Editors
Interests: oxidative stress; inflammation; vascular disease; nanomedicine
Special Issues, Collections and Topics in MDPI journals
Special Issue Information
Dear Colleagues,
Oxidative stress is involved in the pathogenesis of several aging-related diseases such as cardiovascular diseases, neurodegenerative diseases, and cancer. Excessive reactive oxygen (ROS) levels, due to an imbalance in ROS production and its detoxification, cause damage to macromolecules altering various signaling pathways and cell metabolism. While preclinical studies have demonstrated the therapeutic potential of antioxidants, the lack of consistent clinical evidence has driven research toward a new generation of therapeutic approaches. Nanotherapy has emerged as a promising approach for mitigating oxidative stress and its associated effects, thereby offering advantages including targeted delivery, enhanced bioavailability and antioxidant activity, and improved therapeutic efficacy, which minimize side effects. Nanotherapeutics, derived by engineering synthetic and natural nanomaterials, include different molecules such as nanoparticles, nanoemulsions, dendrimers and bioactive cell-secreted nanoparticles like extracellular vesicles.
As the Guest Editors, we invite you to contribute to the Special Issue on “Antioxidant Nano-Therapies for Aging-Related Diseases” with original research papers and reviews that focus on nanotherapeutics as an emerging and promising treatment strategy to counteract oxidative stress-related disease.
Dr. Serena Del Turco
Dr. Luca Menichetti
Guest Editors
Manuscript Submission Information
Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.
Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Antioxidants is an international peer-reviewed open access monthly journal published by MDPI.
Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 2900 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.
Keywords
- oxidative stress
- cardiovascular diseases
- cancer
- redox signaling
- cell biology
- nanotherapeutics
- nanoparticles
- extracellular vesicles
- molecular imaging
- drug delivery
